Intellia Therapeutics (NTLA) Q4 2025 Earnings

6NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-1.33
-1.19
-1.06
-0.92

Details

Expected EPS
-1.005235
Actual EPS
-0.92
Surprise EPS
0.09
Surprise Percent
+8.48%

Description

Intellia Therapeutics (NTLA) has reported earnings of -0.92 per share for Q4 2025.

0 Comments

Share your thoughts